/term/sale-of-ppe/SHSE:688513 Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Sale Of
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » Sale Of Property, Plant, Equipment

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Sale Of Property, Plant, Equipment : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co Sale Of Property, Plant, Equipment?

Chengdu Easton Biopharmaceuticals Co's sale of property, plant, equipment for the three months ended in Mar. 2024 was ¥0 Mil. It means Chengdu Easton Biopharmaceuticals Co gained ¥0 Mil from selling property, plant, and equipment. Chengdu Easton Biopharmaceuticals Co's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Compared with last quarter (¥0 Mil in Dec. 2023 ), Chengdu Easton Biopharmaceuticals Co gained more money from selling property, plant, and equipment in Mar. 2024 (¥0 Mil).


Chengdu Easton Biopharmaceuticals Co Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co Sale Of Property, Plant, Equipment Chart

Chengdu Easton Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Property, Plant, Equipment
Get a 7-Day Free Trial 0.05 0.10 - 0.33 0.26

Chengdu Easton Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 - - 0.03

Chengdu Easton Biopharmaceuticals Co Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengdu Easton Biopharmaceuticals Co Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines